Reaction
Beta 2 Microglobulin Increased reporting signals
As of the last recalculation, Beta 2 Microglobulin Increased appears in 258 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 116.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 14 | 116.5 | 116.6 |
| Dexamethasone Sodium Phosphate | 9 | 74.0 | 74.1 |
| Mesna Injection | 6 | 59.9 | 60.0 |
| Mesna | 6 | 58.8 | 58.9 |
| Entecavir | 8 | 57.0 | 57.1 |
| Febuxostat Tablets 40 Mg | 6 | 48.7 | 48.7 |
| Febuxostat Tablets 80 Mg | 6 | 48.7 | 48.7 |
| Bleomycin Sulfate | 5 | 39.8 | 39.8 |
| Bendamustine Hydrochloride | 4 | 27.4 | 27.4 |
| Ixazomib | 8 | 23.1 | 23.1 |